Marinus Pharmaceuticals | MRNS - Cash And Equivalent


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Marinus Pharmaceuticals

Marinus Pharmaceuticals reported $146.9M in Cash and Equivalent for its fiscal quarter ending in March of 2023.


Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 290.9M 176.05M
ALKERMES ALKS:US USD 321.4M 28.93M
Amgen AMGN:US USD 31.56B 22.26B
Biogen BIIB:US USD 2.9B 521.1M
Eisai 4523:JP JPY 267.35B 652M
Enanta Pharmaceuticals ENTA:US USD 73.18M 30.96M
Esperion Therapeutics ESPR:US USD 144.91M 20.14M
Gilead Sciences GILD:US USD 7.2B 430M
Incyte Corp INCY:US USD 2.82B 130.37M
Intercept Pharmaceuticals ICPT:US USD 61.4M 10.89M
Intra Cellular Therapies ITCI:US USD 75.73M 72.89M
Marinus Pharmaceuticals MRNS:US USD 146.9M 93.65M
Minerva Neurosciences NERV:US USD 35.98M 116K
Neurocrine Biosciences NBIX:US USD 103.8M 159.1M
PTC Therapeutics PTCT:US USD 167.5M 112.34M
Regeneron Pharmaceuticals REGN:US USD 3.92B 810.4M
Sarepta Therapeutics SRPT:US USD 871.67M 95.11M
Supernus Pharmaceuticals SUPN:US USD 58.44M 34.68M
UCB UCB:BB EUR 899M 384M
Vertex Pharmaceuticals VRTX:US USD 9.29B 1.21B